Health News

Race May Influence Angioplasty
Race may play a role in determining which patients are more likely to need repeated procedures to widen narrowed arteries caused by coronary artery disease.
Atypical Drugs Last Longer
With advancements in pharmaceuticals happening every day, many people wonder what differences really exist in novel treatments. Doctors hold the same questions.
New Drug Helping to Reduce Cystic Fibrosis Symptoms
Cystic Fibrosis is a disease that runs in a family. A new drug targeting a specific mutation has been successful so far in helping to treat cystic fibrosis.
"Kicking Cancer's Butt"
"Making Cancer History" is the slogan for The University of Texas MD Anderson Cancer Center.  While the slogan has a double meaning, the organization's new president is keenly focused on keeping that promise and making cancer a disease of the past.
Is Hypertension Linked to Dementia?
Could common conditions such as hypertension, high cholesterol and diabetes influence dementia? New findings suggest a possible link.
New Test for Spotting Kidney Disorder
When it comes to kidney disorders, an early diagnosis can make a huge difference in a patient's outcome. Doctors and patients may soon have a new test that can diagnose a certain kidney disorder in its early stages.
Getting That Blood Sugar Just Right
In order to avoid complications of diabetes, patients have to keep a careful watch on their blood sugar levels. If a diabetes patient also has kidney disease, blood sugar levels may need to be even more precise.
Conscious Children Say "No"
Raising children in a modern environment filled with temptations is not easy. Fortunately, doctors specializing in adolescent behavior continue to research novel treatment to aid parents with their mental health dilemmas.
Re-integrate You
Although the concept of cognitive therapy was developed decades ago, only recent studies analyzed its effects on borderline personality disorder (BPD).
Drug Application for Atrial Fibrillation
Bristol-Myers Squibb Company and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for Eliquis ( apixaban ), an investigational compound for the prevention of stroke and systemic embolism in patients with atrial fibrillation.
<< first135313541355135613571358135913601361last >>

REFINE